These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9668470)

  • 21. A 32 kDa surface antigen of Theileria parva: characterization and immunization studies.
    Skilton RA; Musoke AJ; Wells CW; Yagi Y; Nene V; Spooner PR; Gachanja J; Osaso J; Bishop RP; Morzaria SP
    Parasitology; 2000 Jun; 120 ( Pt 6)():553-64. PubMed ID: 10874718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responses in animals vaccinated with the Theileria annulata (Hisar) cell culture vaccine.
    Beniwal RK; Nichani AK; Sharma RD; Rakha NK; Suri D; Sarup S
    Trop Anim Health Prod; 1997 Nov; 29(4 Suppl):109S-113S. PubMed ID: 9512755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of an insect cell-derived Theileria parva sporozoite vaccine antigen and immunogenicity in cattle.
    Nene V; Inumaru S; McKeever D; Morzaria S; Shaw M; Musoke A
    Infect Immun; 1995 Feb; 63(2):503-8. PubMed ID: 7822014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunity to East Coast fever in cattle induced by a polypeptide fragment of the major surface coat protein of Theileria parva sporozoites.
    Bishop R; Nene V; Staeyert J; Rowlands J; Nyanjui J; Osaso J; Morzaria S; Musoke A
    Vaccine; 2003 Mar; 21(11-12):1205-12. PubMed ID: 12559799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The protection afforded to cattle immunized with Theileria annulata infected cell line is enhanced by subunit vaccine candidate TaSP.
    Saaid AA; Salih DA; Elhaj LM; Abdalla MA; Baumann M; Obara I; Ahmed JS; Clausen PH; El Hussein ARM
    Transbound Emerg Dis; 2020 Mar; 67 Suppl 1():26-34. PubMed ID: 32174037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a recombinant TaSP-based Dot-ELISA for detection of Theileria annulata infection in cattle.
    Mohmad A; Chandra D; Saravanan BC; H V M; O R VK; Fular A; Chigure G; Kaur N; Ghosh S
    Ticks Tick Borne Dis; 2018 Sep; 9(6):1416-1420. PubMed ID: 30207273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macroschizonts of Theileria annulata as vaccine and diagnostic tools.
    Ahmed JS; Shayan P; Hugel FU; Biermann R; Ewald C; Schein E; Gerdes J
    Trop Anim Health Prod; 1997 Nov; 29(4 Suppl):128S-132S. PubMed ID: 9512759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current status of vaccine development against Theileria parasites.
    Morrison WI; McKeever DJ
    Parasitology; 2006; 133 Suppl():S169-87. PubMed ID: 17274845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A recombinant sporozoite surface antigen of Theileria parva induces protection in cattle.
    Musoke A; Morzaria S; Nkonge C; Jones E; Nene V
    Proc Natl Acad Sci U S A; 1992 Jan; 89(2):514-8. PubMed ID: 1731322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterisation of the gene encoding a candidate vaccine antigen of Theileria parva sporozoites.
    Nene V; Iams KP; Gobright E; Musoke AJ
    Mol Biochem Parasitol; 1992 Mar; 51(1):17-27. PubMed ID: 1565135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Theileria annulata: control measures, diagnosis and the potential use of subunit vaccines.
    Tait A; Hall FR
    Rev Sci Tech; 1990 Jun; 9(2):387-403. PubMed ID: 2132687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility to tropical theileriosis of calves born to dams immunized with Theileria annulata (Hisar) cell culture vaccine.
    Beniwal RK; Sharma RD; Nichani AK
    Trop Anim Health Prod; 1998 Dec; 30(6):341-9. PubMed ID: 9974207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro infectivity and in vivo cross-protectivity of Theileria lestoquardi and T. annulata in sheep and cattle.
    Leemans I; Hooshmand-Rad P; Brown CG; Kirvar E; Wilkie G; Uggla A
    Ann N Y Acad Sci; 1998 Jun; 849():408-11. PubMed ID: 9668499
    [No Abstract]   [Full Text] [Related]  

  • 34. Common and stage-specific antigens of Theileria annulata.
    Kachani M; Oliver RA; Brown CG; Ouhelli H; Spooner RL
    Vet Immunol Immunopathol; 1992 Nov; 34(3-4):221-34. PubMed ID: 1280878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Theileria annulata: carrier state and immunity.
    Ilhan T; Williamson S; Kirvar E; Shiels B; Brown CG
    Ann N Y Acad Sci; 1998 Jun; 849():109-25. PubMed ID: 9668456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stage-specific responses following infection with Theileria annulata as evaluated using ELISA.
    Kachani M; Spooner RL; Rae P; Bell-Sakyi L; Brown CG
    Parasitol Res; 1992; 78(1):43-7. PubMed ID: 1584746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective immune responses to Theileria annulata of relevance to vaccine development.
    Preston PM; Visser A; Abraham A; Richardson W; Richardson J; Forsyth L; Bell-Sakyi L; Wilkie G; Entrican G; Boid R; Spooner RL; Brown CG
    Trop Anim Health Prod; 1997 Nov; 29(4 Suppl):136S-138S. PubMed ID: 9512761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccines against Theileria parva.
    Morzaria S; Nene V; Bishop R; Musoke A
    Ann N Y Acad Sci; 2000; 916():464-73. PubMed ID: 11193661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemoprophylaxis of Theileria annulata and Theileria parva infections of calves with buparvaquone.
    Wilkie GM; Brown CG; Kirvar BE; Thomas M; Williamson SM; Bell-Sakyi LJ; Sparagano O
    Vet Parasitol; 1998 Jul; 78(1):1-12. PubMed ID: 9703615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of recombinant antigen vaccines for the control of theileriosis.
    Musoke AJ; Nene V
    Parassitologia; 1990 Apr; 32(1):73-85. PubMed ID: 2149448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.